Title: Retracted: Structural studies of antitumor compounds that target the RING domain of MDM2

Journal Article · · Protein Science
DOI: https://doi.org/10.1002/pro.4367 · OSTI ID:1878430
 [1];  [2];  [1];  [3];  [1];  [4];  [4];  [5];  [5]; ORCiD logo [1]
  1. Center for Diagnostics and Therapeutics Georgia State University Atlanta Georgia USA, Department of Chemistry Georgia State University Atlanta Georgia USA
  2. Institute for Biomedical Sciences Georgia State University Atlanta Georgia USA
  3. Department of Chemistry Georgia State University Atlanta Georgia USA
  4. Department of Chemistry University of Alabama at Birmingham Birmingham Alabama USA
  5. Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy University of Houston Houston Texas USA, Drug Discovery Institute University of Houston Houston Texas USA

Abstract Mouse double minute 2 homolog (MDM2) is an E3 ubiquitin‐protein ligase that is involved in the transfer of ubiquitin to p53 and other protein substrates. The expression of MDM2 is elevated in cancer cells and inhibitors of MDM2 showed potent anticancer activities. Many inhibitors target the p53 binding domain of MDM2. However, inhibitors such as Inulanolide A and MA242 are found to bind the RING domain of MDM2 to block ubiquitin transfer. In this report, crystal structures of MDM2 RING domain in complex with Inulanolide A and MA242 were solved. These inhibitors primarily bind in a hydrophobic site centered at the sidechain of Tyr489 at the C‐terminus of MDM2 RING domain. The C‐terminus of MDM2 RING domain, especially residue Tyr489, is required for ubiquitin discharge induced by MDM2. The binding of these inhibitors at Tyr489 may interrupt interactions between the MDM2 RING domain and the E2‐Ubiquitin complex to inhibit ubiquitin transfer, regardless of what the substrate is. Our results suggest a new mechanism of inhibition of MDM2 E3 activity for a broad spectrum of substrates.

Sponsoring Organization:
USDOE
OSTI ID:
1878430
Journal Information:
Protein Science, Journal Name: Protein Science Journal Issue: 8 Vol. 31; ISSN 0961-8368
Publisher:
Wiley Blackwell (John Wiley & Sons)Copyright Statement
Country of Publication:
United Kingdom
Language:
English

References (32)

TP53 and liver carcinogenesis journal February 2003
Weakly hydrated surfaces and the binding interactions of small biological solutes journal November 2011
The C-terminal SAM domain of p73 binds to the N terminus of MDM2 journal April 2019
MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53 journal September 2019
Putting p53 in Context journal September 2017
Guardian of genome on the tract: Wild type p53-mdm2 complex inhibition in healing the breast cancer journal June 2021
Activation of a Primed RING E3-E2–Ubiquitin Complex by Non-Covalent Ubiquitin journal April 2015
Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment: Miniperspective journal November 2014
Mdm2-mediated ubiquitylation: p53 and beyond journal June 2009
NIH Image to ImageJ: 25 years of image analysis journal June 2012
Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity journal May 2017
MDM2 inhibition: an important step forward in cancer therapy journal July 2020
MDM2 promotes genome instability by ubiquitinating the transcription factor HBP1 journal February 2019
Attenuation of p53 mutant as an approach for treatment Her2-positive cancer journal October 2020
Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain journal April 2020
TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer journal April 2007
Auto-ubiquitination of Mdm2 Enhances Its Substrate Ubiquitin Ligase Activity journal June 2013
It takes a team: a gain-of-function story of p53-R249S journal January 2019
The roles and regulation of MDM2 and MDMX: it is not just about p53 journal April 2021
XDS journal January 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Features and development of Coot journal March 2010
Overview of the CCP 4 suite and current developments journal March 2011
The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure journal January 2014
Comprehensive Analysis of Ebola Virus GP1 in Viral Entry journal March 2005
Discovery and Characterization of Dual Inhibitors of MDM2 and NFAT1 for Pancreatic Cancer Therapy journal October 2018
Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53 journal June 2020
Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy journal April 2016
MDM2 Increases Drug Resistance in Cancer Cells by Inducing EMT Independent of p53 journal December 2016
Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen journal December 2017
Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer journal May 2020
Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers journal March 2012